7 results

  • felbamate

    (Felbamate)
    Novitium Pharma LLC
    Felbamate oral suspension is indicated for patients with severe epilepsy who do not respond to alternative treatments, allowing for its use as monotherapy or adjunctive therapy in partial seizures in adults and Lennox-Gastaut syndrome in children, despite risks of aplastic anemia and liver failure.

  • fludrocortisone acetate

    (Fludrocortisone Acetate)
    Novitium Pharma LLC
    Fludrocortisone acetate tablets, 0.1 mg, are indicated for partial replacement therapy in primary and secondary adrenocortical insufficiency (Addison's disease) and for treating salt-losing adrenogenital syndrome.

  • oxybutynin chloride

    (Oxybutynin Chloride)
    Novitium Pharma LLC
    Oxybutynin chloride tablets are indicated for relieving bladder instability symptoms, including urgency, frequency, urinary leakage, urge incontinence, and dysuria, in patients with uninhibited neurogenic or reflex neurogenic bladder.

  • phenoxybenzamine hydrochloride

    (Phenoxybenzamine Hydrochloride)
    Novitium Pharma LLC
    Phenoxybenzamine Hydrochloride Capsules are indicated for treating pheochromocytoma, specifically to manage hypertension and sweating episodes. If tachycardia occurs excessively, a beta-blocking agent may be needed alongside.

  • prazosin hydrochloride

    (Prazosin Hydrochloride)
    Novitium Pharma LLC
    Prazosin Hydrochloride Capsules are indicated for treating hypertension, effectively lowering blood pressure to reduce the risk of cardiovascular events like strokes and myocardial infarctions. It may be used alone or in combination with other antihypertensive medications as part of an overall cardiovascular risk management strategy.

  • rifabutin

    (Rifabutin)
    Novitium Pharma LLC
    Rifabutin Capsules are indicated for the prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection.

  • selegiline hydrochloride

    (Selegiline Hydrochloride)
    Novitium Pharma LLC
    Selegiline hydrochloride capsules are indicated as an adjunct to levodopa/carbidopa in Parkinsonian patients experiencing diminished response quality. It has shown significant benefits in managing symptoms when combined with levodopa therapy, including reduced 'off' time and improved treatment success measures. No benefit exists without concurrent levodopa.